by McKesson Ventures | May 6, 2020 | Portfolio News
Novartis has announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of its Enerzair® Breezehaler® as a maintenance treatment of asthma in adult patients not...
by McKesson Ventures | May 6, 2020 | Portfolio News
One benefit of the coronavirus pandemic is the increasing usage of telehealth. The virus has forced an end to many non-urgent medical visits, and doctors are connecting with COVID and non-COVID patients virtually. According to Dr. Roy Schoenberg, CEO of telehealth...
by McKesson Ventures | May 6, 2020 | Portfolio News
The COVID-19 crisis has brought telehealth to the forefront as a way to screen for the disease and to manage care for high-risk patients with chronic illnesses. In fact, among U.S. adults, two-thirds said COVID-19 has made them more willing to try telehealth options....
by McKesson Ventures | May 6, 2020 | Portfolio News
There is increasing political pressure to “reopen America” and return to normal life as people’s fears about COVID-19 wane—whether that reduction in fear is reasonable or not. But in order to successfully reopen the United States and contain future COVID-19 outbreaks,...
by McKesson Ventures | Apr 28, 2020 | Portfolio News
United Parcel Service will use drones operated by its airline, UPS Flight Forward, to fill prescriptions from a local CVS for residents of retirement community The Villages in Florida. Delivery by UPS and its drone technology partner, Matternet, to The Villages, may...
by McKesson Ventures | Apr 27, 2020 | Portfolio News
GRAIL has announced that new data for its investigational multi-cancer early detection blood test will be presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting. These new data evaluate the performance of GRAIL’s test in symptomatic...
